Redefining Cardiovascular management through connections that manage.

  Finding the right connection can be the key in preventing and predicting devastating health events like a heart attack. Zuellig Pharma Corp. together with Amger Philippines Inc. aims to help improve awareness of cardiovascular diseases (CVD) with the educational initiatives to achieve the goal of changing the way the disease is managed and prevented.

  In the Philippines, there are over 130,00 death related to Cardiovascular diseases in 2016. CVD is a complex diseases with many risk facts that affects how it develops. One such risk is dyslipidemia, which occurs when one has abnormal level of lipids in the blood. Lipids, or fats are essentials in providing energy to the cells while cholesterol is vital in the production of hormones and bile acids for healthy digestion.

   There are two kinds of cholesterol in the body: Bad and Good cholesterol. Elevated Bad cholesterol, also known as low-density lipoprotein (LDL-C), in the blood increases a person's risk of developing atherosclerotic plaque deposits which can block the arteries and lead to a heart attack or stroke. Lowering LDL-C also lowers a person's chances of developing Cardiovascular diseases.

  The standard treatment for lowering the LDL-C are statins, but there are cases when statins are not enough. Having access to new and innovative treatments in the management of dyslipidemia can make a different for patients who are not able to achieve their lipid goals with statin alone.

  With the patient at the heart of what we do. Amgen Philippines Inc. and Zuellig Pharma Corporation are committed to improve the lives of patients struggling with dyslipidemia by helping them and their families to take necessary action to prevent and manage their health risk.

  But still the best way to prevent the CVD is to get more a healthy lifestyle and manage the food we eat specially with the upcoming Holiday Season.